These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9029387)

  • 1. Risk of recurrence of craniospinal anomalies.
    Papp C; Adám Z; Tóth-Pál E; Török O; Váradi V; Papp Z
    J Matern Fetal Med; 1997; 6(1):53-7. PubMed ID: 9029387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aspects of "uncomplicated" hydrocephalus and its relationship to neural tube defect.
    Laurence KM
    Z Kinderchir; 1984 Dec; 39 Suppl 2():96-9. PubMed ID: 6524107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe fetal hydrocephalus with and without neural tube defect: a comparative study.
    Schlatter D; Sanseverino MT; Schmitt JM; Fritsch A; Kessler RG; Barrios PM; Palma-Dias RS; Magalhães JA
    Fetal Diagn Ther; 2008; 23(1):23-9. PubMed ID: 17934294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hydrocephalus. Clinical significance of associated anomalies and genetic counseling: a pathological approach.
    Roume J; Larroche JC; Razavi-Encha F; Gonzales M; Migne G; Mulliez N
    Genet Couns; 1990; 1(3-4):185-96. PubMed ID: 2098043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic counseling and prenatal diagnosis in families with neural tube defects].
    Mikiel-Kostyra K
    Probl Med Wieku Rozwoj; 1983; 12():244-62. PubMed ID: 6674977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancies of mothers with a neural tube defect child: outcomes and recurrence risks.
    Swerts A; Evers-Kiebooms G; Van den Berghe H
    J Genet Hum; 1987 Dec; 35(5):339-49. PubMed ID: 3437264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recurrence risk for neural tube defects in the United States: a collaborative study.
    Cowchock S; Ainbender E; Prescott G; Crandall B; Lau L; Heller R; Muir WA; Kloza E; Feigelson M; Mennuti M; Cederquist L
    Am J Med Genet; 1980; 5(3):309-14. PubMed ID: 7405962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of fetuses with a pre-termination diagnosis of neural tube defect or hydrocephalus.
    Donnai D; Farndon PA
    Z Kinderchir; 1985 Dec; 40 Suppl 1():51-2. PubMed ID: 4090756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Twenty years of nationwide clinico-epidemiological survey of fetal hydrocephalus in Japan].
    Moritake K; Yamasaki M; Mori K; Kikuchi H
    No Shinkei Geka; 2008 Jan; 36(1):7-24. PubMed ID: 18232318
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity and recurrence risk for congenital hydrocephalus (ventriculomegaly): a prospective study.
    Váradi V; Tóth Z; Török O; Papp Z
    Am J Med Genet; 1988 Feb; 29(2):305-10. PubMed ID: 3354602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric recurrence risk for neural tube defects (NTD) in Krakow region.
    Pietrzyk JJ
    Acta Anthropogenet; 1983; 7(4):367-72. PubMed ID: 6680315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent neural tube defects.
    Goh SL; Tan JV; Kwek KY; Yeo GS
    Singapore Med J; 2006 Aug; 47(8):728-9. PubMed ID: 16865218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated and ventriculomegaly-associated cases of spina bifida in genetic counseling: focus on fetal pathology.
    Joó JG; Csaba Á; Szigeti Z; Rigó J
    Pathol Res Pract; 2013 Jul; 209(7):409-12. PubMed ID: 23706941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural tube malformations: complex segregation analysis and recurrence risk.
    Pietrzyk JJ
    Am J Med Genet; 1980; 7(3):293-300. PubMed ID: 7008595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hydrocephalus: sonographic detection and clinical significance of associated anomalies.
    Nyberg DA; Mack LA; Hirsch J; Pagon RO; Shepard TH
    Radiology; 1987 Apr; 163(1):187-91. PubMed ID: 3547493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: results of a United States study.
    Toriello HV; Higgins JV
    Am J Med Genet; 1983 Aug; 15(4):601-6. PubMed ID: 6614048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief report pregnancy outcome in women assigned an ICD-9/ICD-9-CM 655.0 code "central nervous system malformation in fetus affecting management of pregnancy": can these codes aid in surveillance for central nervous system defects?
    Evans JA
    Birth Defects Res A Clin Mol Teratol; 2014 Nov; 100(11):848-51. PubMed ID: 25073455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of a neural tube defect recurrence-prevention program.
    Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
    Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.